Literature DB >> 24079444

Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy.

Marco Canepa1, Lars L Sorensen, Iraklis Pozios, Veronica L Dimaano, Hong-Chang Luo, Aurelio C Pinheiro, James B Strait, Claudio Brunelli, M Roselle Abraham, Luigi Ferrucci, Theodore P Abraham.   

Abstract

Obesity is independently associated with left ventricular (LV) hypertrophy and thus may be an important modifier of the hypertrophic cardiomyopathy (HC) phenotype. We examined if obesity modifies the clinical presentation, LV morphology, outflow hemodynamics, and exercise tolerance in HC. In this cross-sectional study, 88 obese (body mass index [BMI] ≥30 kg/m(2)) and 154 nonobese (BMI <30 kg/m(2)) patients from the Johns Hopkins HC clinic were compared with respect to a variety of clinical and LV echocardiographic measurements. Obese patients (36.4%) were more likely to report exertional dyspnea (p = 0.04) and chest pain (p = 0.002) and had greater prevalence of hypertension (p = 0.008). LV posterior wall thickness (p = 0.01) but not the septal wall (p ≥0.21) was significantly greater in obese patients, resulting in an increased LV mass index (p = 0.003). No significant differences in LV systolic and diastolic functions were observed, but obesity was associated with higher LV stroke volume (p = 0.03), inducible LV outflow tract gradients (p = 0.045), and chance of developing LV outflow tract obstruction during stress (p = 0.035). In multivariate analysis, BMI was associated with increased posterior (but not septal) wall thickness (β = 0.15, p = 0.02) and LV mass index (β = 0.18, p = 0.005), particularly in those with hypertension. Obesity was also associated with reduced exercise time and functional capacity, and BMI independently correlated with reduced exercise tolerance. In conclusion, obesity is associated with larger LV mass, worse symptoms, lower exercise tolerance, and labile obstructive hemodynamics in HC. The association with increased outflow tract gradients has particular importance as contribution of obesity to the pressure gradients may influence clinical decisions in labile obstructive HC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24079444      PMCID: PMC4042005          DOI: 10.1016/j.amjcard.2013.05.070

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  31 in total

1.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

Review 2.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

3.  Diastolic function is strongly and independently associated with cardiorespiratory fitness in central obesity.

Authors:  M Turzyniecka; S H Wild; A J Krentz; A J Chipperfield; G F Clough; C D Byrne
Journal:  J Appl Physiol (1985)       Date:  2010-03-25

4.  The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Evrim B Turkbey; Robyn L McClelland; Richard A Kronmal; Gregory L Burke; Diane E Bild; Russell P Tracy; Andrew E Arai; João A C Lima; David A Bluemke
Journal:  JACC Cardiovasc Imaging       Date:  2010-03

5.  Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR.

Authors:  Anca Florian; Pier Giorgio Masci; Stijn De Buck; Giovanni Donato Aquaro; Piet Claus; Giancarlo Todiere; Johan Van Cleemput; Massimo Lombardi; Jan Bogaert
Journal:  JACC Cardiovasc Imaging       Date:  2012-07

6.  Blood pressure response to moderate physical activity is increased in obesity.

Authors:  J P W Burger; E H Serne; F Nolte; Y M Smulders
Journal:  Neth J Med       Date:  2009-09       Impact factor: 1.422

7.  Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.

Authors:  J S Shah; M T T Esteban; R Thaman; R Sharma; B Mist; A Pantazis; D Ward; S K Kohli; S P Page; C Demetrescu; E Sevdalis; A Keren; D Pellerin; W J McKenna; P M Elliott
Journal:  Heart       Date:  2007-11-21       Impact factor: 5.994

8.  Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science).

Authors:  Shiriki K Kumanyika; Eva Obarzanek; Nicolas Stettler; Ronny Bell; Alison E Field; Stephen P Fortmann; Barry A Franklin; Matthew W Gillman; Cora E Lewis; Walker Carlos Poston; June Stevens; Yuling Hong
Journal:  Circulation       Date:  2008-06-30       Impact factor: 29.690

9.  Incremental value of left ventricular diastolic function reserve index for predicting exercise capacity in patients with hypertrophic cardiomyopathy.

Authors:  Eui-Young Choi; Jong-Won Ha; Se-Joong Rim; Sung-Ai Kim; Se-Jung Yoon; Chi-Young Shim; Jin-Mi Kim; Yangsoo Jang; Namsik Chung; Seung-Yun Cho
Journal:  J Am Soc Echocardiogr       Date:  2007-09-29       Impact factor: 5.251

10.  The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience.

Authors:  Farhan Aslam; Attiya Haque; Joanne Foody; Jamshid Shirani
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-04       Impact factor: 3.738

View more
  15 in total

1.  Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging).

Authors:  Marco Canepa; Omar Malti; Melissa David; Majd AlGhatrif; James B Strait; Pietro Ameri; Claudio Brunelli; Edward G Lakatta; Luigi Ferrucci; Theodore P Abraham
Journal:  Am J Cardiol       Date:  2014-06-19       Impact factor: 2.778

Review 2.  Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly.

Authors:  Marco Canepa; Iraklis Pozios; Pier Filippo Vianello; Pietro Ameri; Claudio Brunelli; Luigi Ferrucci; Theodore P Abraham
Journal:  Heart       Date:  2016-04-27       Impact factor: 5.994

3.  Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy.

Authors:  Iraklis Pozios; Celia Corona-Villalobos; Lars L Sorensen; Paco E Bravo; Marco Canepa; Chiara Pisanello; Aurelio Pinheiro; Veronica L Dimaano; Hongchang Luo; Zeina Dardari; Xun Zhou; Ihab Kamel; Stefan L Zimmerman; David A Bluemke; M Roselle Abraham; Theodore P Abraham
Journal:  Am J Cardiol       Date:  2015-06-26       Impact factor: 2.778

4.  Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.

Authors:  Carlo Fumagalli; Niccolò Maurizi; Sharlene M Day; Euan A Ashley; Michelle Michels; Steven D Colan; Daniel Jacoby; Niccolò Marchionni; Justin Vincent-Tompkins; Carolyn Y Ho; Iacopo Olivotto
Journal:  JAMA Cardiol       Date:  2020-01-01       Impact factor: 14.676

Review 5.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

6.  Discordant clinical features of identical hypertrophic cardiomyopathy twins.

Authors:  Giuliana G Repetti; Yuri Kim; Alexandre C Pereira; Jodie Ingles; Mark W Russell; Neal K Lakdawala; Carolyn Y Ho; Sharlene Day; Christopher Semsarian; Barbara McDonough; Steven R DePalma; Daniel Quiat; Eric M Green; Christine E Seidman; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 12.779

7.  Obesity and Hypertension in Association with Diastolic Dysfunction Could Reduce Exercise Capacity.

Authors:  JinShil Kim; Myeong Gun Kim; SeWon Kang; Bong Roung Kim; Min Young Baek; Yae Min Park; Mi-Seung Shin
Journal:  Korean Circ J       Date:  2016-04-28       Impact factor: 3.243

8.  Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype.

Authors:  Valeria Guglielmi; Luciano Maresca; Chiara Lanzillo; Giorgia Michela Marinoni; Monica D'Adamo; Mauro Di Roma; Paolo Preziosi; Alfonso Bellia; Leonardo Calò; Paolo Sbraccia
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

Review 9.  Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy.

Authors:  Gherardo Finocchiaro; Emma Magavern; Gianfranco Sinagra; Euan Ashley; Michael Papadakis; Maite Tome-Esteban; Sanjay Sharma; Iacopo Olivotto
Journal:  J Am Heart Assoc       Date:  2017-12-13       Impact factor: 5.501

10.  Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.

Authors:  Dai-Yin Lu; Iraklis Pozios; Bereketeab Haileselassie; Ioannis Ventoulis; Hongyun Liu; Lars L Sorensen; Marco Canepa; Susan Phillip; M Roselle Abraham; Theodore P Abraham
Journal:  J Am Heart Assoc       Date:  2018-02-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.